The Spray Drying of Unfractionated Heparin: Optimization of the Operating Parameters

REFERENCES

• Balfour-Lynn I. M., Klein N. J., Dinwiddie R. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Arch. Dis. Child. 1997; 77: 124–130
   PubMed Web of Science ®Google Scholar
• Bedrossian C. W. M., Greenberg S. D., Singer D. B., Hansen J. J., Rosenberg H. S. The lung in cystic fibrosis. Hum. Pathol. 1976; 7: 195–204
   PubMed Web of Science ®Google Scholar
• Bendstrup K. E., Chambers C. B., Jensen J. I., Newhouse M. T. Lung deposition and clearance of inhaled 99mTc-heparin in healthy volunteers. Am. J. Respir. Crit. Care Med. 1999a; 160: 1653–1658
   PubMed Web of Science ®Google Scholar
• Bendstrup K. E., Gram J., Jensen J. I. Effect of inhaled heparin on lung function and coagulation in healthy volunteers. Eur. Respir. J. 2002; 19: 606–610
   PubMed Web of Science ®Google Scholar
• Bendstrup K. E., Newhouse M. T., Pedersen O. F., Jensen J. I. Characterisation of heparin aerosols generated in jet and ultrasonic nebulisers. J. Aerosol Med. 1999b; 12: 17–25
   PubMedGoogle Scholar
• Blouquit S., Regnier A., Dannhoffer L., Fermanian C., Naline E., Boucher R., Chinet T. Ion and fluid transport properties of small airways in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 299–305
   PubMed Web of Science ®Google Scholar
• Boucher R. C. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J. 2004; 23: 146–158
   PubMed Web of Science ®Google Scholar
• Broadhead J., Rouan S. K. E., Rhodes C. T. The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 1992; 18: 1169–1206
   Web of Science ®Google Scholar
• Broughton-Head V. J., Carroll M. P., Shute J. K. Unfractionated heparin reduces the elasticity and yield stress of CF sputum. J. Cyst. Fibros. 2005; 4(S1)A102
   Google Scholar
• Broughton-Head V. J., Smith J. R., Shur J., Shute J. K. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm. Pharmacol. Ther. 2006, doi:10.1016/j.pupt.2006.08.008
   PubMed Web of Science ®Google Scholar
• Byron P. R., Patton J. S. Drug delivery via the respiratory tract. J. Aerosol Med. Deposition Clear. Eff. Lung 1994; 7: 49–75
   PubMedGoogle Scholar
• Coleman D. E., Montgomery D. C. A systematic approach to planning for a designed industrial experiment. Technometrics 1993; 35: 1–12
   Web of Science ®Google Scholar
• Davis P. B., Drumm M., Konstan M. W. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 1996; 154: 1229–1256
   PubMed Web of Science ®Google Scholar
• de Amorim F. V., Bof C., Franco M. B., da Silva J. B. B., Nascentes C. C. Comparative study of conventional and multivariate methods for aluminium determination in soft drinks by graphite furnace atomic absorption spectroscopy. Microchem. J. 2006; 82: 168–173
   Web of Science ®Google Scholar
• Derringer G., Suich R. Simultaneous optimization of several response variables. J. Qual. Technol. 1980; 12: 214–219
   Web of Science ®Google Scholar
• Fernández C., Hattan C. M., Kerns R. J. Semi-synthetic heparin derivatives: Chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups. Carbohydr. Res. 2006; 341: 1253–1265
   PubMed Web of Science ®Google Scholar
• Frijlink H. W., de Boer A. H. Dry powder inhalers for pulmonary drug delivery. Exp. Opin. Drug Deliv. 2004; 1: 67–86
   PubMedGoogle Scholar
• Garrido-López A., Tena M. T. Experimental design approach for the optimisation of pressurised fluid extraction of additives from polyethylene films. J. Chromatogr. A. 2005; 1099: 75–83
   PubMed Web of Science ®Google Scholar
• Geller D. E. Comparing clinical features of the nebuliser, metered-dose inhaler, and dry powder inhaler. Respir. Care 2005; 50: 1313–1321
   PubMedGoogle Scholar
• Gordon M., Taylor J. S. Ideal co-polymers and the second-order transitions of synthetic rubbers. 1. Non-crystalline co-polymers. J. Appl. Chem. 1952; 2: 493–500
   Web of Science ®Google Scholar
• Haaland P. D. Experimental design in biotechnology. Marcel Dekker, New York 1989
   Google Scholar
• Hancock B. C., Zografi G. The relationship between the glass-transition temperature and the water-content of amorphous pharmaceutical solids. Pharm. Res. 1994; 11: 471–477
   PubMed Web of Science ®Google Scholar
• Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc. Am. Thorac. Soc. 2004; 1: 315–320
   PubMedGoogle Scholar
• Heyder J., Laube B. L., Jashnani R., Dalby R. N., Zeitlin P. L. Targeting aerosol deposition in patients with cystic fibrosis. Effects of alterations in particle size and inspiratory flow rate. Chest 2000; 118: 1069–1076
   PubMed Web of Science ®Google Scholar
• King M., Rubin B. K. Pharmacological approaches to discovery and development of new mucolytic agents. Adv. Drug Deliv. Rev. 2002; 54: 1475–1490
   PubMed Web of Science ®Google Scholar
• Kitson C., Angel B., Judd D., Rothery S., Severs N. J., Dewar A., Huang L., Wadsworth S. C., Cheng S. H., Geddes D. M., Alton E. W. F. W. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 1999; 6: 534–546
   PubMed Web of Science ®Google Scholar
• Le Brun P. P., de Boer A. H., Heijerman H. G., Frijlink H. W. A review of the technical aspects of drug nebulisation. Pharm. World Sci. 2000; 22: 75–81
   PubMed Web of Science ®Google Scholar
• Ledson M., Gallagher M., Hart C. A., Walshaw M. Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients. Eur. Respir. J. 2001; 17: 36–38
   PubMed Web of Science ®Google Scholar
• Lethem M. I., James S. L., Marriott C., Burke J. F. The origin of DNA associated with mucus glycoproteins in cystic-fibrosis sputum. Eur. Respir. J. 1990; 3: 19–23
   PubMed Web of Science ®Google Scholar
• Lewis G. A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical experimental design. Marcel Dekker, New York 1999
   Google Scholar
• Linsdell P. Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp. Physiol. 2006; 91: 123–129
   PubMed Web of Science ®Google Scholar
• Martonen T., Katz I., Cress W. Aerosol deposition as a function of airway disease—cystic-fibrosis. Pharm. Res. 1995; 12: 96–102
   PubMed Web of Science ®Google Scholar
• Masters K. Spray drying handbook 4th. Longman Scientific & Technical and John Wiley and Sons, New York 1985
   Google Scholar
• Millqvist-Fureby A., Elofsson U., Bergenstahl B. Surface composition of spray-dried milk protein-stabilised emulsions in relation to pre-heat treatment of proteins. Colloids Surf. B: Biointerfaces 2001; 21: 47–58
   PubMed Web of Science ®Google Scholar
• Montgomery D. C. Design and analysis of experiments 4th. John Wiley and Sons, New York 1997
   Google Scholar
• Perez-Vilar J., Boucher R. C. Reevaluating gel-forming mucins’ roles in cystic fibrosis lung disease. Free Radic. Biol. Med. 2004; 37: 1564–1577
   PubMed Web of Science ®Google Scholar
• Rezzoug S. A., Capart R. Assessment of wood liquefaction in acidified ethylene glycol using experimental design methodology. Energy Convers. Manage. 2003; 44: 781–792
   Web of Science ®Google Scholar
• Riordan J. R. Assembly of functional CFTR chloride channels. Annu. Rev. Physiol. 2005; 67: 701–718
   PubMed Web of Science ®Google Scholar
• Roos Y. H. Melting and glass transitions of low molecular weight carbohydrates. Carbohydr. Res. 1993; 238: 39–48
   Web of Science ®Google Scholar
• Sanders N. N., De Smedt S. C., Demeester J. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J. Pharm. Sci. 2000; 89: 835–849
   PubMed Web of Science ®Google Scholar
• Serisier D. J., Shute J. K., Hockey P. M., Higgins B., Conway J., Carroll M. P. Inhaled heparin in cystic fibrosis. Eur. Respir. J. 2006; 27: 354–358
   PubMed Web of Science ®Google Scholar
• Simha R., Boyer R. F. On a general relation involving the glass temperature and coefficients of expansion of polymers. J. Chem. Phys. 1962; 37: 1003–1007
   Web of Science ®Google Scholar
• Taguchi G. System of experimental design. Unipub, New York 1987
   Google Scholar
• Tyrrell D. J., Horne A. P., Holme K. R., Preuss J. M., Page C. P. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation. Adv. Pharmacol. 1999; 46: 151–208
   PubMedGoogle Scholar
• Vasconcellos C., Drazen J., Janmey P. A., Wohl M. E., Lind S. E., Stossel T. P. Gelsolin reduces the viscosity of cystic-fibrosis sputum in vitro. Clin. Res. 1993; 41: A283
   Google Scholar